Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
about
Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancerScreening the low molecular weight fraction of human serum using ATR-IR spectroscopy.
P2860
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
@ast
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
@en
type
label
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
@ast
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
@en
prefLabel
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
@ast
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
@en
P2093
P2860
P50
P356
P1476
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer
@en
P2093
Joanna Hajduk
Krystian Pawlak
Wojciech Dyszkiewicz
Zenon J Kokot
P2860
P356
10.3390/IJMS17040410
P407
P577
2016-03-31T00:00:00Z